BAZ1A and malignant colon neoplasm: This might provide a clue to the phenotypic outcomes in colon cancers following BAZ1A interference, disrupting the activity of ATP-utilizing chromatin assembly and remodeling factor (ACF) complexes (Fig. 8F).